Top 5 Undervalued Stocks of 2026

08 June 2026

What are the most undervalued stocks of 2026? Learn the metrics value investors use, with real examples from the Axiory CFD list. Read more.

Key Takeaways

Undervalued stocks are companies trading below what they ‘should be worth’. This can be due to a myriad of choices, but the most important part is that we think the company is currently more expensive than its true price, and we expect the market to ‘correctly’ price it in the future.
Some of the core metrics value investors lean on are the P/E ratio, price-to-book, and free cash flow yield. However, these too are just a part of the picture, just as important are brand strength, management and a company's moat
The deepest value currently clusters in European automakers, restructuring banks, and a defensive pharma name.
In this article we are focusing mostly on value investing, using analysis to find solid, profit-making companies which are priced too cheaply. However, in value investing there is also the risk of the value trap: companies which seem too cheap based on their financials, but despite that never see any increases in price.

Most of the attention currently goes to the same handful of names it always has: the mega-cap technology giants that dominate the headlines and the indices alike. But while everyone crowds into the most expensive corner of the market, value tends to be located elsewhere. Some genuinely solid businesses end up trading at prices that look too low, and there is profit to be found in locating these stocks before others do.

This article walks through how to identify the most undervalued stocks of 2026, which metrics matter, and what the numbers currently show across the stock CFDs available at Axiory.

What Makes a Stock Undervalued?

A stock is considered undervalued when its market price sits below what we think the business is worth. We are not looking for stocks which are genuinely struggling and thus rightfully becoming cheaper. The whole approach revolves around finding undervalued stocks and buying them before everyone else finds out they are too cheap, and they thus become correctly priced.

The catch is that a low price, by itself, tells you almost nothing. The real skill is separating a genuine bargain from a value trap: a stock that's cheap because the business is slowly dying. That distinction is what the rest of this article is about.

Which Metrics Reveal Value?

In investing, as well as in trading, we can never rely on just one data point. Whether it’s a support zone on a chart, or a specific financial ratio, we always want confluence of data points to even consider taking on risk. In trading, a position opened in one asset is one that is not allocated towards a different one, the opportunity cost is huge in global markets as we have them today. The list below is a very short overview of what we consider to be the best metrics, however they in no way tell the complete story:

1. The P/E Ratio

The price-to-earnings (P/E) ratio compares a company's share price to its earnings per share, and it's the most widely used valuation metric of all. Benjamin Graham famously wanted to see a P/E no higher than around 15 for a defensive purchase. P/E is best used to filter out companies which are only slightly profitable or in general just overvalued. However, past that initial hurdle, the importance of P/E as a metric drops off.

2. Price-to-Book

The price-to-book (P/B) ratio compares what the market is willing to pay for a company against what the company is actually worth on paper. To work it out, you take the share price and divide it by the company's book value per share.

So, what is book value? In simple terms, it's what would theoretically be left over for shareholders if the company sold everything it owns (its assets, such as cash, buildings, and equipment) and paid off everything it owes (its liabilities, such as debts and bills).

Reading the ratio is straightforward once you have it. A P/B below 1 means the market is pricing the company at less than the stated value of its own net assets, it would mean that in theory, you could buy out the company, completely dismantle it, and make money from doing so. To see P/B this low, however, is very rare, as companies tend to be profitable and thus be worth more than the sum of their parts.

3. Free Cash Flow Yield

The third pillar is the most down-to-earth of the three, because it's about plain cash. Think of a household: money comes in from your salary, and money goes out on bills, food, and the cost of keeping the house running. Whatever is genuinely left over at the end of the month, the amount you could save, invest, or spend freely, is what matters. Companies work the same way, and that leftover amount has a name: free cash flow.

The free cash flow yield then turns that into an easy comparison. It takes the spare cash and shows it as a percentage of what the whole company is worth on the stock market: you simply divide the free cash flow by the company's total market value. For example, if a company produces 8 dollars of spare cash for every 100 dollars its shares are worth, that's a free cash flow yield of 8%. The simple rule: the higher the percentage, the more cash you're getting for your money, and the better the value tends to be.

Why do seasoned investors lean on this number so heavily? Because cash is much harder to fake than profit. A company can make its profits look bigger or smaller through accounting choices, but cash either arrives in the bank account, or it doesn't. That makes free cash flow yield one of the most trustworthy signs that a stock is genuinely cheap rather than just looking cheap on paper. As a rough benchmark, when the yield comfortably beats what you'd earn from a safe government bond, investors are being rewarded for taking on the extra risk of owning shares.

Comparison of the P/E ratio, price-to-book and free cash flow yield valuation metrics

The Five Most Undervalued Stocks of 2026

Screening all stocks against these three metrics: low earnings multiple, support from the balance sheet, and healthy cash generation, means five names stand out.

One thing worth keeping in mind as we go: each of these stocks is cheap for a reason. The job isn't to find a low number and stop there, it's to ask whether the market's pessimism is pointing at a fixable problem or a permanent decline. That question is what separates a bargain from a value trap, and we'll keep coming back to it.

1. Volkswagen

If we sort the entire U.S. and European large-cap stock market list by forward earnings, Volkswagen sits right at the bottom, and it isn't particularly close. The stock trades at a P/E of roughly 7. The market is pricing one of the largest carmakers on the planet (the owner of Audi, Porsche, Škoda and Lamborghini) as though its profits are about to be permanently impaired.

The reason isn't a mystery. Volkswagen is caught between aggressive Chinese EV competitors eating into its markets. On top of that, the cash flow test shows that free cash flow has been thin and volatile, at times turning negative, meaning the company has at points been spending more cash than what operations (selling cars) bring in. This shows up in a free cash flow yield of only around 1%.

These downsides don't necessarily make it a value trap however, as these are investments being made specifically to combat the risk of Chinese EVs. This is where your own insight comes in, are you convinced that Volkswagen will be able to overcome this threat and turn the current investments into future profits? If so, this is a value stock with solid growth potential.

2. Mercedes-Benz

Mercedes-Benz trades at a forward P/E of around 9, but the figure that catches the eye is its price-to-book of roughly 0.65. As we discussed earlier, a P/B below 1 means you're being offered the company for less than the stated value of its own net assets, meaning that you could theoretically buy out the company and strip it apart to make money.

Where this gets interesting is the comparison with Volkswagen. Where VW stumbles on the cash test, Mercedes holds up far better: with a free cash flow yield of around 4%, it generates several times the cash relative to its size that Volkswagen does, which tells us the cheap valuation is backed by real money coming through the door, not just an optimistic reading of the books. On a relative basis it trades at roughly 9 times earnings against a global auto industry average closer to 17.

It carries the same China and tariff overhang as Volkswagen, so this is no free lunch. But among the cheap automakers, Mercedes pairs the stronger brand and the better margins with the healthier cash position, arguably making it an even better option than Volkswagen.

3. Citigroup

Banks have re-rated sharply over the past year, and most of them are no longer cheap. Citigroup might be the exception. Even after a strong run, it trades at a forward P/E of around 11 and still sits at roughly its book value, which gives us that asset-backed cushion underneath the price.

A quick note on method here, because banks don't quite play by the same rules. The free cash flow test we leaned on for the other names doesn't translate cleanly to a bank, since lending, deposits and regulatory capital make their cash flows work very differently. For banks, the more telling gauge is return on equity, essentially, how much profit they earn for every dollar shareholders invest. Citi's ROE still trails its peers, and that lower number reflects why the stock is cheap, but it also means every step Citi takes toward peer-level returns helps justify a higher valuation, making it an interesting play while this catch-up has not yet been completed.

4. Barclays

If Citigroup is the cheap American bank, Barclays is its European counterpart, and on the raw numbers it's even cheaper with a forward P/E at 7.4. Like Citi, it continues to trade below its tangible book value despite a solid recovery.

The discount reflects a familiar set of worries: general skepticism toward UK and European banks, and the hard-to-forecast earnings of its investment-banking arm. Those concerns are fair. But the business underneath has been steadily improving, with returns now approaching double digits, and it pairs neatly with Citigroup as a second turnaround-bank story.

5. Pfizer

Our final name brings some welcome diversification, because a list made up purely of carmakers and banks would be leaning very hard on just two stories.

Pfizer's trailing P/E looks unremarkable at around 19 to 20, but that figure is distorted by the post-pandemic earnings comparison it's still working through. The forward P/E sits closer to 9. The real selling point, however, is its free cash flow yield of roughly 7%. The company is building a strong cash position, allowing it to either reinvest these profits into new research or distribute it to shareholders, both scenarios which generally help stocks to go up. However, there is also a reason the stock is this cheap, as the market rarely gives a free lunch. Several of Pfizer's most important patents are set to expire in the coming years, allowing competitors to make the same medication, and thus strongly diminishing expected revenue. But that strong cash generation, combined with a generous dividend, suggests a lot of the pessimism is already reflected in the price.

Comparison table showing P/E, price-to-book and free cash flow yield for five undervalued stocks

Why Are These Stocks So Cheap?

It would be easy to read the five names above as five separate ideas. What we really have is three underlying stories: that the market is too pessimistic on legacy automakers facing Chinese competition (Volkswagen and Mercedes), that two restructuring banks will close the gap on their peers (Citigroup and Barclays), and that Pfizer's cash generation can carry it through its patent cliff.

That matters for how we think about risk. Volkswagen and Mercedes will tend to move together on any China headline, just as Citigroup and Barclays will react to the same shifts in the rate and credit cycle. So, while we have five tickers, we're really making three bets, and any position sizing must account for those overlaps rather than mistaking them for true diversification.

And to come back to where we started: in every one of these cases, the cheap valuation is there for a reason. The low multiple is the market telling us about a real risk, not handing us a guaranteed bargain. Value investing works over the long run precisely because it asks us to sit with that discomfort while we wait for the story to change, and to accept that sometimes the story doesn't change at all.

How Can You Research Value Stocks Yourself?

The framework above is repeatable. Start by screening for a low P/E, then sanity-check it against price-to-book and free cash flow yield. After that comes the hard part: asking whether the market's fear concerns a fixable problem or a permanent decline. Reading earnings reports, tracking sector news, and understanding the macro backdrop all feed into that judgment. Our Weekly Market Pulse and Trading Academy are good places to keep building that context.

Conclusion

Value hasn't disappeared in 2026, it has simply moved to the corners of the market that everyone else is avoiding: out-of-favor European automakers, restructuring banks, and a pharma giant staring down a patent cliff. None of these are comfortable stories to own, which is exactly why they seem cheap in the first place. Whether that discomfort turns into profit depends, as always, on whether the market's fears prove overdone or well-founded, and that's a judgment each of us has to make on our own.